Model: Short Dyn Ensemble

Performance 1/25/19 - 2/2/23
logo
Investment Approach
Model: Short Dyn Ensemble
Performance Versus Benchmark (ProShares Short S&P500 Total Return) 1/25/19 to 2/2/23
Strategy Overall Bench Overall Strategy YTD Bench YTD
Abs. Return -190.0% -49.3% 2.6% -7.9%
Rel. Return -140.7% N/A 10.4% N/A
Beta 0.41 N/A -0.20 N/A
Ann. Volatility 20.3% 22.8% 4.9% 15.7%
Sharpe -0.57 -0.60 6.01 -4.86
Drawdown -176.8% -58.4% 0.0% -8.6%
IR 0.11 N/A 5.52 N/A
Tracking Error 22.4% N/A 19.8% N/A
Historical Summary
1 Yr 2 Yr 3 Yr 5 Yr 10 Yr
Ann. Return � � � � N/A
Ann. Volatility 19.1% 18.3% 21.4% 20.3% N/A
Performance Attribution
Risk/Return versus benchmark
Monthly Return Comparison Trailing 12 Months
Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Total
Strategy 0.3% 4.8% -2.0% 1.9% -1.4% 2.2% 5.5% -253.3% 1.9% -0.4% 1.6% 0.9% -278.1%
Benchmark -4.1% 9.1% -1.0% 8.5% -8.6% 4.2% 9.9% -7.7% -5.3% 6.5% -5.6% -2.4% 0.9%
Rel. Return 4.4% -4.3% -1.0% -6.6% 7.2% -2.0% -4.4% -245.6% 7.3% -6.9% 7.2% 3.3% -279.0%
Perspective on Performance
  
Model: Short Dyn Ensemble

Model: Short Dyn Ensemble

Strategy Performance Analysis by Neuravest
logo
Performance Report
Performance Chart
Correlation
Beta
Exposure
  
Performance Metrics
Portfolio Initial Adjusted Final Adjusted Return Compound Annual Return
Model: Short Dyn Ensemble$998,897($898,813)($899.K 0.0%
ProShares Short S&P500$29.13$14.77($14.36) -15.4%
Portfolio Return Sharpe Sortino Ann. Volatility Max Drawdown
Model: Short Dyn Ensemble-190.0%-0.57-0.66 20.3% 176.8%
ProShares Short S&P500-49.3%-0.60-0.86 22.8% 58.4%

Transaction Cost:
Number of Transactions2,000
Total Commissions ($0.0035 per share, $2.95 min per trade)$7,675
Slippage$1,864
Borrowing CostsN/A
Total Transaction Costs$9,539
Benchmark Relative Metrics:
Beta0.41
Information Ratio0.11
Annualized Tracking Error22.4%

Trade Analysis
Trade Metrics (Successful):
Metric Long Short All
# Trades 1 (100.0%) 700 (49.3%) 701 (49.3%)
Avg Gain 2.48% 4.57% 4.57%
Avg Hold Time 1 days 1 weeks 1 weeks
Trade Metrics (Unsuccessful):
Metric Long Short All
# Trades 0 (0.0%) 720 (50.7%) 720 (50.7%)
Avg Loss 0.00% -5.88% -5.88%
Avg Hold Time less than a second 1 weeks 1 weeks

Best Long Trade:
Ticker Open Date Close Date Hold Time Pnl Amount Weighted Pnl
AA Aug 4, 2021 1:42:58 PM Aug 6, 2021 9:30:04 AM 1 days 2.5% $1,423.68 0.2%

Worst Long Trade:
Ticker Open Date Close Date Hold Time Pnl Amount Weighted Pnl
AA Aug 4, 2021 1:42:58 PM Aug 6, 2021 9:30:04 AM 1 days 2.5% $1,423.68 0.2%

Best Short Trade:
Ticker Open Date Close Date Hold Time Pnl Amount Weighted Pnl
CHKAQ Apr 27, 2020 9:30:57 AM Apr 30, 2020 9:31:24 AM 3 days 53.5% $26,742.78 3.3%

Worst Short Trade:
Ticker Open Date Close Date Hold Time Pnl Amount Weighted Pnl
EXAS Aug 31, 2020 9:30:24 AM Sep 25, 2020 9:41:08 AM 3 weeks -25.3% ($19,236.48) -2.5%

Performance Metrics By Year
2019 2020 2021 2022 2023
ReturnStrategy -1.5% -38.2% -12.2% -264.3% 2.6%
ProShares Short S&P500 -17.9% -25.1% -24.2% 18.1% -7.9%
Winning DaysStrategy 47.9% 41.9% 48.4% 51.4% 68.2%
ProShares Short S&P500 40.3% 42.3% 40.9% 55.0% 36.4%
SharpeStrategy -0.01 -1.68 -0.67 0.40 6.01
ProShares Short S&P500 -1.66 -0.67 -2.07 0.81 -4.86
SortinoStrategy -0.02 -1.90 -0.72 0.54 11.07
ProShares Short S&P500 -2.91 -0.95 -3.40 1.33 -7.63
Max DDStrategy 19.0% 41.3% 21.8% 256.8% 0.0%
ProShares Short S&P500 18.4% 44.7% 25.6% 15.2% 8.6%
Ann. VolatilityStrategy 16.8% 26.4% 17.3% 19.7% 4.9%
ProShares Short S&P500 11.8% 34.3% 13.0% 24.2% 15.7%
  

Monthly Return to Benchmark By Year
JanFebMarAprMayJunJulAugSepOctNovDecTotal
2019 Strategy -0.3% -2.7% -1.5% 1.3% 7.4% -2.0% 5.4% 4.6% 0.3% -2.9% -1.9% -8.5% -1.5%
Benchmark -2.4% -2.9% -1.7% -3.5% 7.0% -6.3% -1.2% 1.6% -1.7% -2.0% -3.4% -2.6% -17.9%
Relative Return 2.1% 0.3% 0.2% 4.8% 0.5% 4.3% 6.6% 3.1% 2.1% -0.9% 1.5% -5.8% 16.4%
 
2020 Strategy 1.4% -4.0% -2.3% -11.2% -9.4% -0.4% 1.8% -0.2% -4.7% -11.5% -4.7% -0.8% -38.2%
Benchmark 0.2% 8.6% 6.0% -12.5% -5.0% -2.7% -5.6% -6.8% 3.3% 2.1% -10.0% -3.7% -25.1%
Relative Return 1.2% -12.5% -8.4% 1.3% -4.4% 2.3% 7.4% 6.5% -7.9% -13.6% 5.4% 3.0% -13.2%
 
2021 Strategy 4.9% -2.5% -2.2% -0.3% 3.5% -9.7% 0.5% 1.0% 2.7% -5.7% -6.8% 2.8% -12.2%
Benchmark 0.7% -2.9% -4.7% -5.1% -0.9% -2.4% -2.5% -3.1% 4.7% -6.8% 0.6% -4.6% -24.2%
Relative Return 4.2% 0.4% 2.4% 4.7% 4.3% -7.3% 3.1% 4.0% -2.0% 1.1% -7.3% 7.5% 12.0%
 
2022 Strategy 0.1% -5.5% 0.3% 4.8% -2.0% 1.9% -1.4% 2.2% 5.5% -253.3% 1.9% -0.4% -264.3%
Benchmark 5.1% 2.6% -4.1% 9.1% -1.0% 8.5% -8.6% 4.2% 9.9% -7.7% -5.3% 6.5% 18.1%
Relative Return -5.1% -8.0% 4.4% -4.3% -1.0% -6.6% 7.2% -2.0% -4.4% -245.6% 7.3% -6.9% -282.4%
 
2023 Strategy 1.6% 0.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.6%
Benchmark -5.6% -2.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -7.9%
Relative Return 7.2% 3.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 10.4%
 
Monthly Turnover By Year
JanFebMarAprMayJunJulAugSepOctNovDecTotal
2019 15.2% 136.6% 182.2% 167.7% 177.6% 163.5% 161.8% 178.9% 208.8% 232.0% 175.4% 116.2% 1,916.0%
2020 197.9% 140.0% 139.3% 199.2% 215.3% 125.6% 201.0% 195.0% 166.6% 189.0% 160.3% 138.9% 2,068.2%
2021 180.9% 169.3% 201.8% 192.9% 211.1% 152.1% 89.6% 191.4% 151.7% 161.2% 192.9% 164.8% 2,059.7%
2022 93.0% 153.7% 150.9% 161.8% 195.6% 156.7% 89.2% 169.0% 90.5% -0.1% -0.0% -0.0% 1,260.3%
2023 -0.0% -0.0% N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A -0.0%
  

FOR QUALIFIED INSTITUTIONAL INVESTOR USE ONLY. NOT INTENDED FOR INDIVIDUAL RETAIL INVESTORS.

Investment advisory services provided by Neuravest Research Inc., a registered investment adviser. Registration as an investment adviser does not imply a certain level of skill or training. Nothing presented herein has been approved or verified by the United States Securities and Exchange Commission or by any self regulatory organization (SRO), or state securities authority.

Information presented herein is hypothetical and solely for informational purposes only, and should not be construed as an offer to buy or a solicitation of an offer to sell any security or other investment product. Though we have endeavored to present the information contained herein from sources believed to be reliable, we cannot guarantee the accuracy of such information and make no warranties or representations as such.

All investments involve risks that an investor should fully understand and be willing to bear. Past performance is no guarantee of future returns, and investing can result in partial or complete loss of invested capital. Such risks can be magnified to the extent leverage is deployed in the pursuit of potentially higher returns.

To the extent investment returns are presented, such investment returns are either hypothetically backtested or reflect a perpetual paper trading simulation and are labeled as such. Returns are presented as net returns of transaction costs, slippage and short borrowing costs (when applicable). Investment returns are also net of Neuravest standard annualized management fees of 40 basis points (on Assets Under Management) and 10% performance fee on excess return above an 8% hurdle. Investment returns presented reflect the reinvestment of dividends and other earnings, however they do not account for taxes that an investor may owe as a result of any investment gains. Investors may incur taxes as a result of investing, and may pay different transaction costs to the ones presented to the broker-dealer executing the transactions for their account(s).

Hypothetical backtested returns are simulated, retroactive, and created using the benefit of hindsight to a select period of time, and are thus inherently not as reflective of actual historical returns. Any hypothetical backtested returns are based on the following assumptions and criteria:

  • Actual price was available for execution
  • Capacity and daily float was supportive of volume traded.
  • Transaction cost and slippage are reflective of real-world brokerage fees.

Hypothetical backtested returns do not reflect actual trading and do not reflect the impact that material economic and market factors may have had on Neuravest’s algorithmic decision-making at the time.

To the extent investment performance is compared to one or more indexes, investors should be aware that one cannot invest directly into an index (a simulated basket of securities that do not reflect fees, costs, or taxes that an investor may actually incur).

Neuravest Research and its affiliates do not provide tax, legal or accounting advice. This material has been prepared for informational purposes only, and is not intended to provide, and should not be relied on for, tax, legal or accounting advice. You should consult your personal tax, legal and accounting advisors before engaging in any transaction.

Asset allocation/diversification or hedging does not guarantee a profit or protect against a loss.

Performance fees may vary depending upon executed leverage.

NEURAVEST RESEARCH INC (CRD# 312803/SEC#: 801-120607)